8
MILTSOV ET AL.
5.3.3 | bis-2,5-[2-(1-Ethyl-1,3-dihydro-
3,3-dimethyl-2H-indol-2-ylidene)
butadienyl-1,3-idene]-cyclohexanone (13c)
132.01, 132.53, 136.13, 137.94, 139.36, 139.83, 143.55,
143.91, 158.35, 162.57, 192.97. ES-MS+ [M + H]+ 505.3210
(cal. [M + H]+ = 5 053 219 for C35H41N2O). λmax
(base)
(EtOH) = 579.0 nm (ε 3.30·104 L mol−1 cm−1). λmax (acid)
Dark-brown solid; m.p.: 127ꢀC-131ꢀC. From 2а and 5b
(EtOH) = 811.0 nm (ε 7.10·104 L mol−1 cm−1).
1
yield 195 mg (36%). H NMR (CDCl3): δ 1.26 (m, 6H),
1.62 (s, 12 H), 1.83 (m, 2H), 2.68 (m, 4H), 3.69 (m, 4H),
5.54 (d, J = 12.0 Hz, 2H), 6.27 (m, 2H), 6.66 (d, J = 8 Hz,
2H), 6.90 (m, 2H), 7.13-7.24 (m, 4H), 7.31 (m, 2H), 7.55
(d, J = 12.0 Hz, 2H). 13C NMR (CDCl3): δ 11.38, 22.54,
26.56, 28.24, 36.86, 46.14, 96.86, 106.25, 120.00, 120.11,
121.74, 127.76, 130.32, 137.84, 138.74, 139.39, 143.87,
158.68, 188.00. ES-MS+ [M + H]+ 5 453 519 (cal. [M
ACKNOWLEDGMENTS
We acknowledge the Center for Magnetic Resonance
and the Center for Chemical Analysis and Materials
Research of Saint Petersburg State University for per-
forming the NMR and ES-MS studies. The work is
carried out according to the State Assignment from
the Ministry of Education and Science of the Russian
Federation (Reg. no. АААА-А16-116071450048-3) and
funded by Ministerio de Economía y Competitividad
(Project CTQ2012-36165) and Generalitat de Catalu-
nya (2014SGR837).
+ H]+ = 5 453 532 for C38H45N2O). λmax
(base)
(EtOH) = 585.0 nm (ε 5.42·104 L mol−1 cm−1). λmax (acid)
(EtOH) = 893 nm (ε 1.14·105 L mol−1 cm−1).
ORCID
5.3.4 | bis-2,5-[2-(3-Ethyl-1,3-dihydro-
1,1-dimethyl-2H-benz[e]indol-2-ylidene)
butadienyl-1,3-idene]-cyclohexanone (13d)
REFERENCES
Dark-brown solid; m.p.: 160ꢀC-164ꢀC. From 2b and 5b
yield 309 mg (48%). 1H NMR (CDCl3): δ 1.31 (m, 6H), 1.86
(m, 2H), 1.95 (s, 12 H), 2.71 (m, 4H), 3.80 (m, 4H), 5.58 (d,
J = 12.0 Hz, 2H), 6.30 (m, 2H), 7.06 (d, J = 8.5 Hz, 2H),
7.28 (m, 2H), 7.3-7.53 (m, 4H), 7.62 (d, J = 12.0 Hz, 2H),
7.77 (d, J = 8.5 Hz, 2H), 7.82 (d, J = 8 Hz, 2H), 8.04 (d,
J = 8.5 Hz, 2H). 13C NMR (CDCl3): δ 11.75, 22.59, 26.61,
27.40, 36.98, 48.13, 96.54, 108.98, 119.90, 121.72, 122.34,
126.79, 129.08, 129.32, 129.49, 129.80, 130.28, 137.92,
138.71, 141.27, 160.64, 187.92. ES-MS+ [M + H]+ 6 453 837
[1] L. Strekowski, M. Lipowska, G. Patonay, Synth. Commun.
1992, 22, 2593.
[2] L. Strekowski, M. Lipowska, G. Patonay, J. Org. Chem. 1992,
57, 4578.
[3] G. Patonay, G. Casay, M. Lipowska, L. Strekowski, Talanta
1993, 40, 935.
[4] M. Puyol, C. Encinas, L. Rivera, S. Mitsov, J. Alonso, Sens
Actuat. B Chem. 2006, 115, 287.
[5] A. Beletskii, M. Cooper, P. Sriraman, C. Chiriac, L. H. Zhao,
S. Abbot, L. M. Yu, Biotechniques. 2005, 39, 894.
[6] R. M. Rosenberg, R. M. Herreid, G. J. Piazza, M. H. Oleary,
Anal. Biochem. 1989, 181, 59.
[7] J. Duy, R. L. Smith, S. D. Collins, L. B. Connell, Biosens.
Bioelectron. 2014, 52, 433.
[8] A. Gerasov, M. Shandura, Y. Kovtun, M. Losytskyy,
V. Negrutska, I. Dubey, Anal. Biochem. 2012, 420, 115.
[9] A. Dodge, K. Fluri, E. Verpoorte, N. F. de Rooij, Anal. Chem.
2001, 73, 3400.
[10] B. B. S. Guirgis, C. S. Cunha, I. Gomes, M. Cavadas, I. Silva,
G. Doria, G. L. Blatch, P. V. Baptista, E. Pereira,
H. M. E. Azzazy, M. M. Mota, M. Prudêncio, R. Franco, Anal.
Bioanal Chem. 2012, 402, 1019.
(cal. [M + H]+ = 6 453 845 for C46H49N2O). λmax
(base)
(EtOH) = 606.0 nm (ε 4.09s·104 L mol−1 cm−1). λmax (acid)
(EtOH) = 930.0 nm (ε 8.08·104 L mol−1 cm−1).
5.3.5 | 2-[2-(1-Ethyl-1,3-dihydro-
3,3-dimethyl-2H-indol-2-ylidene)
butadienyl-1,3-idene]-5-[2-(1-ethyl-
1,3-dihydro-3,3-dimethyl-2H-indol-
2-ylidene)ethyliden]-cyclopentanone (14)
[11] J. Yang, Z. Baocun, C. Jihua, D. Xiaohong, Theranostics 2015,
5, 173.
[12] G. Zhiqian, P. Sookil, Y. Juyoung, S. Injae, Chem. Soc. Rev.
2014, 43, 16.
Dark-brown solid; m.p.: 142ꢀC-144ꢀC. From 2а and 7 yield
1
221 mg (44%). H NMR (CDCl3): δ 1.22 (m, 3H), 1.34 (m,
[13] M. E. Cooper, S. Gregory, E. Adie, S. Kalinka, J. Fluoresc.
2002, 12, 425.
3H), 1.62 (s, 6 H), 1.68 (s, 6 H), 2.77 (s, 4H), 3.69 (m, 2H),
3.77 (m, 2H), 5.39 (d, J = 13.0 Hz, 1H), 5.55 (d, J = 12.0 Hz,
1H), 6.18 (dd, J1 = 14.0 Hz, J2 = 12.0 Hz, 1H), 6.67 (d,
J = 8.0 Hz, 1H), 6.72 (d, J = 8.0 Hz, 1H), 6.90 (m, 1H), 6.96
(m, 1H), 7.12-7.34 (m, 6H), 7.79 (d, J = 13.0 Hz, 1H). 13C
NMR (CDCl3): δ 11.11, 11.37, 23.82, 23.88, 28.24, 28.52,
36.85, 37.13, 46.11, 46.71, 93.16, 96.82, 106.22, 106.65,
120.09, 120.80, 121.11, 127.73, 127.84, 127.75, 129.38,
[14] S. Seo, S. Pascal, C. Park, K. Shin, X. Yang, O. Maury,
B. D. Sarwade, C. Andraud, E. Kim, Chem. Sci. 2014, 5, 1538.
[15] S. Pascal, S. Denis-Quanquin, F. Appaix, A. Duperray,
A. Grichine, B. Guennic, D. Jacquemin, J. Cuny, S. H. Chi,
J. W. Perry, B. van der Sanden, C. Monnereau, C. Andraud,
O. Maury, Chem. Sci. 2016, 8, 381.
[16] S. W. Hell, Nat. Biotechnol. 2003, 21, 1347.